title: Expression of atrophy-related transcription factors in the process of intrinsic laryngeal muscle atrophy after denervation.
abstract: We examined changes in the expressions of three atrophy-related transcription factors (FOXO3a, P-FOXO3a, and PGC-1α) in the process of intrinsic laryngeal muscle atrophy after denervation. In total, 51 Wistar rats were used. After transection of the unilateral recurrent laryngeal nerve, the thyroarytenoid (TA) muscle and the posterior cricoarytenoid (PCA) muscle were excised and subjected to histological and Western blot studies. Relationships between the expressions of transcription factors during atrophy of the intrinsic laryngeal muscles were investigated by comparing the results of the treated side (T) with those of the untreated side (U), and sequential changes in the T/U ratio after denervation were assessed. Loss of wet muscle weight, together with a decrease in muscle fiber cross-sectional area and increase in the number of muscle fibers/mm(2), occurred more quickly in TA muscle than in PCA muscle. Muscle atrophy progressed rapidly between 7 and 28 days after denervation, while expression of FOXO3a was maximal on day 7, in both TA and PCA muscles. By contrast, P-FOXO3a expression decreased gradually after denervation. Expression of PGC-1α increased slowly until day 7, and then it declined. Denervation-induced atrophy of the intrinsic laryngeal muscles was closely linked with the expression of FOXO3a and PGC-1α, suggesting that atrophy of these muscles may involve the actions of these transcription factors. In addition, muscle atrophy progressed faster in TA muscle than in PCA muscle, due mainly to differences in muscle fiber composition.
authors.affiliation: Department of Otolaryngology, Ehime University School of Medicine, Shitsukawa, Toon, Ehime, 91-0295, Japan, hirofumisei@gmail.com.
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Sei
authors.forename: Aki
authors.initials: A
authors.lastname: Taguchi
authors.forename: Naoya
authors.initials: N
authors.lastname: Nishida
authors.forename: Naohito
authors.initials: N
authors.lastname: Hato
authors.forename: Kiyofumi
authors.initials: K
authors.lastname: Gyo
mesh_terms: D000818:Animals; D015153:Blotting, Western; D003714:Denervation / Q000009:adverse effects*; D007821:Laryngeal Muscles / Q000294:innervation / Q000378:metabolism* / Q000473:pathology; D008297:Male; D009133:Muscular Atrophy / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar; D012009:Recurrent Laryngeal Nerve / Q000601:surgery*; D014157:Transcription Factors / Q000096:biosynthesis*
chemical_list: D014157:Transcription Factors
references.citation: Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16260-5
references.pmid: 17053067
references.citation: J Physiol Sci. 2011 Nov;61(6):537-46
references.pmid: 21901639
references.citation: Laryngoscope. 1998 Aug;108(8 Pt 1):1225-9
references.pmid: 9707248
references.citation: Laryngoscope. 2012 May;122(5):1093-8
references.pmid: 22374515
references.citation: Laryngoscope. 2010 Feb;120(2):353-8
references.pmid: 19957344
references.citation: Biochem J. 1976 Apr 15;156(1):71-80
references.pmid: 942405
references.citation: Cell. 2004 Apr 30;117(3):399-412
references.pmid: 15109499
references.citation: Eur Arch Otorhinolaryngol. 2013 Mar;270(3):975-84
references.pmid: 23100084
references.citation: J Biol Chem. 2010 Jun 18;285(25):19460-71
references.pmid: 20404331
references.citation: BMC Biol. 2013 Feb 01;11:12
references.pmid: 23374633
references.citation: Mol Cell. 2004 May 7;14(3):395-403
references.pmid: 15125842
references.citation: FASEB J. 2007 Jan;21(1):140-55
references.pmid: 17116744
references.citation: Am J Physiol Cell Physiol. 2012 Feb 1;302(3):C587-96
references.pmid: 22094330
references.citation: PLoS One. 2014 Jan 31;9(1):e87587
references.pmid: 24498144